Pure Global AI
Manufacturer profile

DIA PRO DIAGNOSTIC BIOPROBES S.R.L.

BrazilItaly20 ANVISA registrations9 unique technical categoriesJan 07, 2008 – Jan 02, 2023
Verified
20
Total products
9
Technical names
Jan 2008
Earliest registration
Jan 2023
Latest registration
Regulatory footprint
Search DIA PRO DIAGNOSTIC BIOPROBES S.R.L. across other regulatory registries
ThailandEuropean UnionColombiaSouth KoreaCanadaEcuador
Recent registrations
Latest 5 products registered by this manufacturer
ANTINUCLEAR ANTIBODY (ANA)
DIA.CHEMILUX IgG anti-Sm
Class II · Jan 02, 2023
ANTINUCLEAR ANTIBODY (ANA)
DIA.CHEMILUX IgG anti-RNP
Class II · Jan 02, 2023
ANTINUCLEAR ANTIBODY (ANA)
DIA.CHEMILUX IgG anti-JO1
Class II · Jan 02, 2023
ANTINUCLEAR ANTIBODY (ANA)
DIA.CHEMILUX IgG anti-SSB
Class II · Jan 02, 2023
ANTINUCLEAR ANTIBODY (ANA)
DIA.CHEMILUX IgG anti-SCL70
Class II · Jan 02, 2023
Most popular products
Products with most registrations
ANTINUCLEAR ANTIBODY (ANA)
10 registrations
HEPATITIS E VIRUS (HEV)
2 registrations
HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG)
2 registrations
ANTICORPOS TOTAIS PARA TREPONEMA PALIDUM
1 registrations
ANTICORPO PARA VÍRUS DE T-LINFOTRÓPICO HUMANO 1 E 2 (HTLV1 E HTLV2)
1 registrations
Top registration holders
Companies holding product registrations for this manufacturer
GOYAZES BIOTECNOLOGIA LTDA
10 products
AUREUM COMERCIO DE PRODUTOS MEDICOS E DIAGNOSTICOS LTDA
5 products
GMRB COMÉRCIO DE PRODUTOS MÉDICOS E DIAGNÓSTICOS LTDA
5 products
Top competitors
Companies with the most overlapping products (same technical names)
DIA.PRO DIAGNOSTIC BIOPROBES SRL
Italy
26 registrations8 shared products
Shared products
ANTICORPO PARA VÍRUS DE T-LINFOTRÓPICO HUMANO 1 E 2 (HTLV1 E HTLV2), ANTICORPOS TOTAIS PARA TREPONEMA PALIDUM, ANTINUCLEAR ANTIBODY (ANA), CHIKUNGUNYA, HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG), HEPATITIS D VIRUS (HDV), IMUNOGLOBULINA G (IgG) PARA VÍRUS ZIKA, TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV)
DIASORIN ITALIA S.P.A.
Italy
11 registrations7 shared products
Shared products
ANTICORPO PARA VÍRUS DE T-LINFOTRÓPICO HUMANO 1 E 2 (HTLV1 E HTLV2), ANTICORPOS TOTAIS PARA TREPONEMA PALIDUM, ANTINUCLEAR ANTIBODY (ANA), HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG), HEPATITIS D VIRUS (HDV), HEPATITIS E VIRUS (HEV), TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV)
ROCHE DIAGNOSTICS GMBH
Germany
14 registrations5 shared products
Shared products
ANTICORPO PARA VÍRUS DE T-LINFOTRÓPICO HUMANO 1 E 2 (HTLV1 E HTLV2), ANTICORPOS TOTAIS PARA TREPONEMA PALIDUM, HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG), HEPATITIS E VIRUS (HEV), TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV)
QUIBASA QUÍMICA BÁSICA LTDA
Brazil
12 registrations5 shared products
Shared products
ANTICORPO PARA VÍRUS DE T-LINFOTRÓPICO HUMANO 1 E 2 (HTLV1 E HTLV2), ANTICORPOS TOTAIS PARA TREPONEMA PALIDUM, CHIKUNGUNYA, HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG), TOTAL ANTIBODY TO HEPATITIS C VIRUS (ANTI-HCV)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
China
10 registrations5 shared products
Shared products
ANTICORPO PARA VÍRUS DE T-LINFOTRÓPICO HUMANO 1 E 2 (HTLV1 E HTLV2), ANTICORPO TOTAL PARA VÍRUS DE HEPATITE C (ANTI-HCV), ANTICORPOS TOTAIS PARA TREPONEMA PALIDUM, ANTINUCLEAR ANTIBODY (ANA), HEPATITIS B VIRUS SURFACE ANTIGEN (HBSAG)
About this profile

Explore comprehensive manufacturer profile for DIA PRO DIAGNOSTIC BIOPROBES S.R.L. based in Italy through Pure Global AI's free Brazil medical device database. This manufacturer has 20 products registered with ANVISA across 9 unique technical categories. Their regulatory history spans from Jan 07, 2008 to Jan 02, 2023.

This page provides detailed insights including 5 recent product registrations including ANTINUCLEAR ANTIBODY (ANA), 5 most popular products with ANTINUCLEAR ANTIBODY (ANA) having 10 registrations, 3 registration holders including GOYAZES BIOTECNOLOGIA LTDA, and 5 key competitors with DIA.PRO DIAGNOSTIC BIOPROBES SRL sharing 8 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.